OpGen - Addressing AMR with next-generation sequencing

OpGen has announced the launch of its next-generation sequencing (NGS) services in the United States at its new Rockville-based service laboratory. The NGS lab, developed by its subsidiary Ares Genetics, offers short-turnaround genome sequencing of clinical isolates, artificial intelligence (AI) powered outbreak analysis that can be conveniently accessed through the company's AREScloud web application. The closer proximity to a large US customer base allows OpGen to better leverage its Ares Genetics suite of products, expands its portfolio of services in the United States - in addition to the recent launch of Acuitas AMR Gene Panel - and increases cross-selling opportunities.

Den vollständigen Artikel lesen ...